NNMT inhibition follows dose-dependent curves: 50mg produces 4050% enzyme inhibition, 100mg achieves 6075%, with diminishing returns beyond 150mg
Bottom Line 5A1MQ is a small molecule (~159 to 175 Da), not a peptide
Most patients turn the corner at some point within the first 10-14 days after starting B12 therapy
Bibliography Gjurasin M, Miklic P, Zupancic B, Perovic D, Zarkovic K, Brcic L, Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury
Contact your GP immediately, call NHS 111, or attend A&E if you develop: Irregular heartbeat or palpitations that persist Chest pain or pressure Severe breathlessness Significant leg swelling These symptoms require assessment to determine their cause, which may or may not be related to your B12 treatment